MoneyWorks4Me

Smruthi Organics - Quaterly Results

27 Jul 2024 Evaluate
A decrease in the sales to Rs. 272.73 millions was observed for the quarter ended June 2024. The sales stood at Rs. 349.12 millions during the similar quarter previous year.The Net Loss for the quarter ended June 2024 is Rs. -9.22 millions as compared to Net Profit of Rs. 22.94 millions of corresponding quarter ended June 2023Operating profit for the quarter ended June 2024 decreased to 4.48 millions as compared to 46.29 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 272.73 349.12 -21.88 272.73 349.12 -21.88 1276.43 1410.41 -9.50
Other Income 0.02 0.11 -81.82 0.02 0.11 -81.82 0.76 1.07 -28.97
PBIDT 4.48 46.29 -90.32 4.48 46.29 -90.32 120.31 98.87 21.69
Interest 4.08 3.25 25.54 4.08 3.25 25.54 14.08 8.22 71.29
PBDT 0.40 43.04 -99.07 0.40 43.04 -99.07 106.23 90.65 17.19
Depreciation 12.94 12.38 4.52 12.94 12.38 4.52 56.53 45.72 23.64
PBT -12.54 30.66 -140.90 -12.54 30.66 -140.90 49.70 44.93 10.62
TAX -3.32 7.72 -143.01 -3.32 7.72 -143.01 13.79 3.63 279.89
Deferred Tax -3.32 -1.13 193.81 -3.32 -1.13 193.81 -2.27 -10.97 -79.31
PAT -9.22 22.94 -140.19 -9.22 22.94 -140.19 35.91 41.30 -13.05
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 1.64 13.26 -87.61 1.64 13.26 -87.61 9.43 7.01 34.46
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..